Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal  Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side  Effects of Prostate Radiation Therapy - Palette Life Sciences

Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Palette Life Sciences

4.6
(651)
Write Review
More
$ 22.00
Add to Cart
In stock
Description

Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectum SANTA BARBARA, CALIF. / STOCKHOLM, SWEDEN – June 9, 2022— Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of […]

James Leech on LinkedIn: Palette Life Sciences Announces FDA 510(k

Palette Life Sciences on LinkedIn: Palette Life Sciences Announces

Proof-of-principle Phase I results of combining nivolumab with

Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel

Barrigel Proven Safe & Effective at Minimizing Side Effects

Barrigel on LinkedIn: Palette Life Sciences Announces FDA 510(k

Helena Jansson på LinkedIn: Palette Life Sciences Announces FDA

About Your Barrigel Procedure for Prostate Cancer Radiation

Rick Wymer on LinkedIn: Palette Life Sciences Announces FDA 510(k

Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel

Rick Wymer on LinkedIn: Palette Life Sciences Announces FDA 510(k

Helena Jansson på LinkedIn: Palette Life Sciences Announces FDA